Press release
Global Cerebral Thrombectomy Devices Market Scenario Highlighting Major Drivers & Trends, 2018-2026 // Angiotech, Chestnut Medical Technologies, Inc., Abbott, Concentric Medical, Inc., NexGen Medical Systems, Cordis, Possis Medical, Inc., EKOS Corporation
Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=2703
Thrombectomy is the surgical removal of blood clots formed in blood vessels. The removal of blood clots from the blood vessels in the brain is known as cerebral thrombectomy and the devices used for the same are known as cerebral thrombectomy devices. Blockage in blood vessels in the brain can be caused due to various reasons such as atheroma, an embolus or a thrombus of one or more arteries. A blood clot may lead to the draining or leakage of blood into the brain, if left untreated. More than 90% of strokes account for cerebral infarction in the United States. According to the Centers for Disease Control and Prevention (CDC), around 130,000 Americans are killed by strokes every year. Cerebral infraction is an ischemic stroke that results in a lack of blood supply to the brain. The risk factors associated with cerebral infraction include diabetes, high blood pressure, tobacco smoking, hyperlipoproteinemia, atherosclerosis, obesity and hypercholesterolemia.
The rising incidence rate of chronic kidney disease, which is one of the causative factors of cerebral venous thrombosis, is expected to fuel the cerebral thrombectomy devices market growth. Recent advancements in products in the cerebral thrombectomy devices market by manufacturers are expected to drive the growth of the market.
On the other hand, the high treatment cost associated with cerebral thrombectomy may hamper the growth potential of the cerebral thrombectomy devices market. Low awareness and availability of skilled professionals for cerebral thrombectomy may impede the cerebral thrombectomy devices market growth.
To know more about the Cerebral Thrombectomy Devices Market Visit the link- https://www.factmr.com/report/2703/cerebral-thrombectomy-devices-market
Cerebral Thrombectomy Devices Market: Overview
The rapidly increasing incidence rate of ischemic strokes is the major driver for the cerebral thrombectomy devices market. The global cerebral thrombectomy devices market, on the basis of product type, is expected to be dominated by the snare segment, owing to the higher adoption of these devices by healthcare professionals for cerebral thrombectomy. On the basis of end user, the cerebral thrombectomy devices market is expected to be dominated by the hospitals segment, due to the higher patient footfall for treatment. Manufacturers in the cerebral thrombectomy devices market are focusing on manufacturing advanced products for better patient compliance and to make the procedure easier.
Cerebral Thrombectomy Devices Market: Regional Outlook
The global cerebral thrombectomy devices market is expected to be dominated by North America, due to the higher adoption of these devices and the number of surgical procedures being performed using cerebral thrombectomy devices. Europe is expected to be the second most lucrative cerebral thrombectomy devices market, due to the higher incidences of cerebral venous thrombosis. Asia-Pacific is expected to be the fastest growing cerebral thrombectomy devices market due to rapidly improving healthcare infrastructure, coupled with the increasing penetration of cerebral thrombectomy devices and increasing availability of skilled professionals. The Latin America cerebral thrombectomy devices market is expected to witness steady growth, due to the improving product penetration in the region. The Middle East and Africa cerebral thrombectomy devices market is expected to be the least lucrative market, due to the low treatment seeking rate and comparatively less developed healthcare infrastructure in major regions.
Cerebral Thrombectomy Devices Market: Market Participants
Examples of some of the market participants in the global cerebral thrombectomy devices market include Penumbra, Inc., Stryker Corporation, Boston Scientific Corporation, ev3 Inc., Angiotech, Chestnut Medical Technologies, Inc., Abbott, Concentric Medical, Inc., NexGen Medical Systems, Cordis, Possis Medical, Inc., EKOS Corporation, Terumo Corporation, Medtronic plc and others.
Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=2703
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - http://theguardiantribune.com
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Cerebral Thrombectomy Devices Market Scenario Highlighting Major Drivers & Trends, 2018-2026 // Angiotech, Chestnut Medical Technologies, Inc., Abbott, Concentric Medical, Inc., NexGen Medical Systems, Cordis, Possis Medical, Inc., EKOS Corporation here
News-ID: 1544363 • Views: …
More Releases from Fact.MR
Organic Fertilizer Market is Set to Hit US$ 16,673.5 Million at a CAGR of 6.4% b …
According to Fact.MR, the organic fertilizer market is anticipated to expand at a 6.4% CAGR between 2024 and 2034. The global market for these goods is anticipated to grow to US$ 16,673.5 million by 2034. Market research and competitive intelligence firm Fact MR states that the worldwide organic fertilizer market is expanding quickly and is predicted to maintain this development trajectory in the upcoming years.
The organic fertilizer industry can see…
Home Healthcare Market to Cross US$ 8,78,383.5 Million, Rising at a CAGR of 9.8% …
The global home healthcare industry is expected to be worth US$3,45,256.6 million in 2024. Through 2034, the market is expected to expand rapidly at a 9.8% CAGR. By 2034, the market is expected to grow to US$ 8,78,383.5 million.
There is an increasing need for in-home healthcare services as the number of senior people rises. Additionally, there is a growing need for the specialized care provided by home healthcare professionals due…
CAR T-Cell Therapy Market Size is Expected to Reach a Value of US$ 11.49 Billion …
The market for CAR T-cell treatment is expected to grow at an astounding 17.7% CAGR from 2024 to 2034, with a projected valuation of US$ 2.25 million in 2024.
Increased leukemia incidence, a surge in research and development to generate novel CAR T-cell therapy, and CAR T-cell therapy's better efficacy over other conventional cancer treatments are the main factors driving the market growth for CAR T-cell therapy.
𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟…
Allyl Polyether Market Expected to Grow at 4.5% CAGR to US$ 99.1 Million by 2033
The global Allyl Polyether Market (アリルポリエーテル市場) was valued at approximately US$ 63.8 million in 2023 and is projected to reach around US$ 99.1 million by the end of 2033, growing at a compound annual growth rate (CAGR) of 4.5%.
The Allyl Polyether Market is a segment of the polymer industry that has been witnessing steady growth in recent years. This growth can be attributed to several factors, including the increasing demand…
More Releases for Cerebral
Industry Dynamics of Cerebral Malaria Therapeutics
Global Cerebral Malaria Therapeutics Market: Overview
Cerebral malaria, a severe neuropathological complication, primarily caused by Plasmodium falciparum. The infectious disease has become prevalent in tropical and sub-tropical countries. The cerebral malaria therapeutics market has evolved on the back of increased understanding of pathogenesis of the neurological syndrome. A growing array of biomarkers and tool in recent years have helped underpin the growing revenue potential in the market, giving rise to numerous…
Cerebral Palsy Therapeutics Clinical Trials & Results
In cerebral palsy, the term cerebral refers to brain and palsy refers to the loss or impairment of motor function. Cerebral palsy is a group of neurological disorders that appear in infancy or early childhood, and permanently affect body movement and muscle coordination.
Download the sample report @ https://www.pharmaproff.com/request-sample/1093
It is caused by damage or abnormalities inside the developing brain that disrupt its ability to control movement and maintain posture and balance.…
Finding confidence and independence with cerebral palsy
Yemina is an active, fun and smart twelve year old from Canada who loves to read or hang out with friends. She also has cerebral palsy which affects all of her movement and her level of independence. Her mum, Shoshana, explains that Yemina's cerebral palsy makes any activity involving movement a challenge, but particularly those involving hand control. "She has a lot of extra movement through her…
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has…
Cerebral Palsy - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Cerebral Palsy - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cerebral Palsy - Pipeline Review, H1 2017, provides an overview of the Cerebral Palsy (Central Nervous System) pipeline landscape.
Cerebral palsy is a group of disorders that can involve brain and nervous system functions, such as…
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has…
